LAUSR

IntroductionProlactin (PRL) is a sex hormone with immunomodulatory properties, and it is associated with the clinical activity of rheumatoid arthritis (RA). The -1149G>T polymorphism at the prolactin (PRL) gene has been associated with autoimmune diseases, but its functional effect is unclear.ObjectiveTo analyze the association of the PRL -1149G>T polymorphism with disease susceptibility, mRNA, and protein expression of PRL in RA patients from Southern Mexico.MethodsWe included 300 RA patients and 300 control subjects (CS). Genotypes were identified by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique, the PRL mRNA expression was determined by real-time PCR, and PRL serum levels were measured by enzyme-linked immunosorbent assay.ResultsApplying genetic models of inheritance (dominant, recessive, and additive), we found an association between the T allele and decreased RA susceptibility (OR = 0.55, 95% CI 0.35–0.87, p = 0.009; OR = 0.09, 95% CI 0.012–0.76, p = 0.011; OR = 0.49, 95% CI 0.32–0.76, p = 0.001, respectively). RA patients had higher mRNA expression and soluble levels of PRL than CS (p < 0.05). The PRL serum levels were similar in RA and CS according to genotypes. However, in CS, carriers of GT and TT genotypes showed lower PRL mRNA expression than GG genotype carriers (7.1-fold and 20-fold respectively, p = 0.006).ConclusionsThis study demonstrated that the PRL -1149T allele is a genetic marker of decrease risk to RA in population from Southern Mexico, and it is associated with low PRL mRNA.Key Points• PRL -1149T allele is a marker of decreased RA susceptibility in population from southern Mexico.• PRL -1149TT genotype is associated with low PRL mRNA expression.• RA patients have higher mRNA expression and soluble levels of PRL than healthy subjects.• PRL serum levels are higher in those RA patients with < 2 years of disease evolution.